Source: http://www.google.com/patents/US4590201?dq=7,339,580
Timestamp: 2017-10-17 04:32:04
Document Index: 31243923

Matched Legal Cases: ['art 24', 'art 24', 'art 18', 'art 18', 'art 16', 'art 16']

Patent US4590201 - 5-amino or substituted amino 1,2,3-triazoles - Google Patents
Novel 5-amino or substituted amino 1,2,3-triazoles are disclosed as having anticoccidial activity. The compounds are useful for controlling coccidiosis when administered in minor quantities to animals, in particular to poultry, usually in admixture with animal sustenance....http://www.google.com/patents/US4590201?utm_source=gb-gplus-sharePatent US4590201 - 5-amino or substituted amino 1,2,3-triazoles
Publication number US4590201 A
Application number US 06/576,301
Also published as DE3584100D1, EP0151529A2, EP0151529A3, EP0151529B1
Publication number 06576301, 576301, US 4590201 A, US 4590201A, US-A-4590201, US4590201 A, US4590201A
Inventors Richard J. Bochis, John C. Chabala, Michael H. Fisher
Patent Citations (3), Non-Patent Citations (25), Referenced by (36), Classifications (42), Legal Events (4)
US 4590201 A
US3948885 * Mar 19, 1973 Apr 6, 1976 Icn Pharmaceuticals, Inc. 5-Hydroxyl-1,2,3-triazole-4-carboxamide nucleoside
US4341700 * Jan 9, 1979 Jul 27, 1982 Sandoz Ltd. Monoazo compounds having a substituted 1,2,3-triazolyl-5 diazo component radical and an unsubstituted or substituted 1,4-phenylene coupling component radical
GB1511195A * Title not available
1 * Ajinomoto Co. Inc.: Triazole 4 Carboxylic Acids, CA 94(1): 4027(c) (1980).
2 Ajinomoto Co. Inc.: Triazole-4-Carboxylic Acids, CA 94(1): 4027(c) (1980).
3 * Albert, A. I: V Triazolo 4,5 d pyrimidines: part 24 3 alkyl, Derw. CA 95 (17): 150600w (1981).
4 Albert, A. I: V-Triazolo [4,5--d]pyrimidines: part 24--3 alkyl, Derw. CA 95 (17): 150600w (1981).
5 * Albert, A. II: V Triazolo Pyrimidines: Part 18 3 mm for Synthesizing 8 azupurinationes: CA 86(23): 171374e (1977).
6 Albert, A. II: V-Triazolo Pyrimidines: Part 18--3 mm for Synthesizing 8-azupurinationes: CA 86(23): 171374e (1977).
7 * Albert, A. III: V Triazolo Pyrimidines: Part 16: Prep. of 6 Amino 8 Azaparines by Heating, CA 82(25): 170802y.
8 Albert, A. III: V-Triazolo Pyrimidines: Part 16: Prep. of 6-Amino-8 Azaparines by Heating, CA 82(25): 170802y.
9 * Albert, A. IV: 1,2,3 Triazole Analogs of 2 Aminobenzylamine, CA 73(15): 77154t (1970).
10 Albert, A. IV: 1,2,3 Triazole Analogs of 2-Aminobenzylamine, CA 73(15): 77154t (1970).
11 * Albert, A. V: Dimroth Rearrangement Part XV: Catalysis by Methylamine Salts, CA 80(15): 82890d.
12 * Calautti et al: New Coccideostatic Drugs of Iamino 9H 1,2 4 Triazole Series, CA 76(17): 99572s.
13 Calautti et al: New Coccideostatic Drugs of Iamino-9H-1,2-4 Triazole Series, CA 76(17): 99572s.
14 * Da Settino et al II: 1 2 3 Triazole Deriv. of Arylalkanoic Acids: Farmaco Ed. Sci. 34(5) 371 382 (1979).
15 Da Settino et al II: 1-2-3 Triazole Deriv. of Arylalkanoic Acids: Farmaco Ed. Sci. 34(5) 371-382 (1979).
16 * DeSehimo et al: Synthesizing Pharmacological Activity of 9-aryl Sazadenine Inv. Farmaco Ed Sci., 35(4) 308 323 (1980).
17 DeSehimo et al: Synthesizing Pharmacological Activity of 9-aryl-Sazadenine Inv. Farmaco Ed-Sci., 35(4) 308-323 (1980).
18 * Ferlauto, R.: Controlling Coccidiosis in Poultry Employing Triazole Deriv., CA 75(13) 87461w (1971).
19 * Itamader et al; Triazole Anticoccidium Agents: CA 83(15) 126969e (1975).
20 * Levine, H. B.: Comparison of Oral Treatments with Bay in 7133 Ketaconozole, CA 100(17): 132137t (1984).
21 * Lucacchini et al Effects of Subst. 1,2 3 Triazole on a Dinosine Duninore etc. Ital. J. Biochem. 28(3) 194 206 (1979).
22 Lucacchini et al--Effects of Subst. 1,2-3 Triazole on a Dinosine Duninore etc. Ital. J. Biochem. 28(3) 194-206 (1979).
23 * Peters et al; Inhibiting Pavine Biosynthesis Ing 4(5) Aminoamidozoles 5(4)Carboxamides, CA 68 (23): 103631q (1968).
24 Peters et al; Inhibiting Pavine Biosynthesis Ing 4(5) Aminoamidozoles-5(4)Carboxamides, CA 68 (23): 103631q (1968).
25 * Tennant: Chem. of Polyazohetero. Cupts VI Dimrotarearray. of Triazoles, CA 74 (23): 125581z (1971).
US4721791 * May 19, 1986 Jan 26, 1988 Merck & Co., Inc. 5-amino or substituted amino 1,2,3-triazoles
US4752611 * Nov 29, 1985 Jun 21, 1988 Merck & Co., Inc. Anticoccidial 1,2,3-trazole compounds
US4816469 * Nov 6, 1987 Mar 28, 1989 Merck & Co., Inc. 5-Amino or substituted amino 1,2,3-triazoles
US4847257 * Aug 20, 1987 Jul 11, 1989 Merck & Co., Inc. 5-Amino or substituted amino 1,2,3,-triazoles useful as antiproliferative agents
US4923885 * Aug 19, 1988 May 8, 1990 Merck & Co., Inc. 5-amino-1-(4-naphthoylbenzyl)-1,2,3-triazole-4-carboxamides and analogs as antiproliferative agents
US4950673 * Aug 18, 1988 Aug 21, 1990 Merck & Co., Inc. 5-amino or substituted amino 1,2,3-triazoles
US5015651 * Dec 6, 1988 May 14, 1991 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
US5045543 * May 8, 1989 Sep 3, 1991 Merck & Co., Inc. 5-amino or substituted amino 1,2,3-triazoles useful as antimetastatic agents
US5081127 * Mar 26, 1990 Jan 14, 1992 E. I. Du Pont De Nemours And Company Substituted 1,2,3-triazole angiotensin II antagonists
US5093346 * Mar 8, 1991 Mar 3, 1992 E. I. Du Pont De Nemours And Company Substituted 1,2,4-triazole angiotensin II antagonists
US5189048 * Jul 10, 1991 Feb 23, 1993 E. I. Du Pont De Nemours And Company Substituted 1,2,3 triazole angiotensin II antagonists
US5315013 * Aug 5, 1992 May 24, 1994 E. I. Du Pont De Nemours And Company Substituted pyrazole angiotensin II antagonists
US5405782 * Mar 31, 1993 Apr 11, 1995 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Detection and quantitation method for therapeutic agents in blood
US5482954 * Jul 1, 1994 Jan 9, 1996 The United States Of America As Represented By The Department Of Health And Human Services Signal transduction inhibitor triazole and diazole compounds
US5498620 * May 31, 1995 Mar 12, 1996 The United States Of America As Represented By The Department Of Health And Human Services Signal transduction inhibitor 1,2,3-triazolo compounds
US5705514 * May 31, 1995 Jan 6, 1998 The United States Of America As Represented By The Department Of Health And Human Services Signal transduction inhibitor compounds
US5744492 * Mar 10, 1994 Apr 28, 1998 United States Of America Method for inhibiting angiogenesis
US5861406 * Jul 18, 1996 Jan 19, 1999 Constantia Gruppe Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
US5880129 * Aug 5, 1997 Mar 9, 1999 The United States Of America As Represented By The Department Of Health And Human Services Methods of inhibiting invasion and metastasis of malignant solid tumors
US5912346 * Nov 10, 1997 Jun 15, 1999 Constantia Gruppe Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
US8377973 * Sep 3, 2010 Feb 19, 2013 Tactical Therapeutics Inc Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
US8912223 Jan 16, 2013 Dec 16, 2014 Tactical Therapeutics Inc Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazoles orotate formulations
US20110060142 * Sep 3, 2010 Mar 10, 2011 Karmali Rashida A Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
CN100493609C Jan 19, 2005 Jun 3, 2009 中国医学科学院基础医学研究所 Medicine composition for treating malignant tumours and application
CN104817507A * Sep 3, 2010 Aug 5, 2015 巧妙疗法股份有限公司 Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
EP2963023A1 Sep 3, 2010 Jan 6, 2016 Tactical Therapeutics Inc. Process for preparing 5-amino-1, 2, 3-triazole orotate derivatives
WO1990014009A1 * May 18, 1990 Nov 29, 1990 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Therapeutic application of an anti-invasion compound
WO2006076854A1 * Jan 10, 2006 Jul 27, 2006 Institute Of Basic Medical Sciences, Chinese Academy Of Medical Sciences Combination medication for malignant tumors and application
WO2011028288A1 Sep 3, 2010 Mar 10, 2011 Tactical Therapeutics, Inc Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
U.S. Classification 514/359, 548/255
International Classification C07D249/06, C07F7/18, C07C49/813, C07C63/70, C07C45/67, A01N43/36, A61P33/02, C07C45/63, C07C45/45, C07D249/04, C07C45/46, A61K31/41, C07C45/42
Cooperative Classification C07D249/06, C07C317/00, C07D249/04, C07C247/00, C07C45/42, C07C45/46, C07C323/00, C07C45/673, C07C45/45, C07F7/1852, C07C45/63, C07C49/813, C07C255/00
European Classification C07C255/00, C07C247/00, C07C323/00, C07C317/00, C07C45/42, C07C45/67C, C07C45/45, C07C45/46, C07C45/63, C07F7/18C4D4C, C07C63/70, C07D249/04, C07D249/06, C07C49/813